Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; May2023, Vol. 11 Issue 5, p415-424, 10p
- Subject
COVID-19 OLDER patients ANTIVIRAL agents HOSPITAL patients MEDICAL care - Language
- ISSN
- 22132600